New cancer drug begins first human safety tests
Disease control
Recruiting now
This early-stage study is testing a new drug called ORB-021 in people with advanced solid tumors that haven't responded to standard treatments. The main goal is to check if the drug is safe and to find the best dose for future studies. Researchers will give the drug through an IV…
Phase: PHASE1 • Sponsor: Orionis Biosciences Inc • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC